Clinical trial · Interventional
RISE - Reduce Sitting Time Among Breast Cancer Survivors
RISE - A Pilot Study to Reduce Sitting Time Among Breast Cancer Survivors
NCT05260723CI-TRIAL-00066391completedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This 3-month study will test whether a program to reduce sitting time, for breast cancer survivors experiencing some physical limitations, can improve their physical function and other important aspects of quality of life.
Conditions
Conditions (3)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Cancer | Malignant Breast Neoplasm | CURATED_EXACT | 0.92 |
| Sedentary Behavior | — | UNRESOLVED | — |
| Sedentary Time | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Behavioral: Sit Less | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- Sit Less
- description
- The primary goal of the Sit Less arm is to reduce the total amount of time spent sitting each day and break up prolonged bouts of sitting.
- interventionNames
- Behavioral: Behavioral: Sit Less
Primary outcomes (1)
- measure
- Retention rate of enrolled participants
- timeFrame
- 3 months
- description
- Percent of participants returning for the 3 month measures
Secondary outcomes (4)
- measure
- 4 meter walk test
- timeFrame
- 3 months
- description
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 50 Years
Show eligibility criteria text
Inclusion Criteria: * Breast cancer survivors (stages I-IV) at least 1 year post active treatment (e.g., chemotherapy, radiotherapy) * Breast cancer was treated with chemotherapy, radiation, immunotherapy, and/or endocrine therapy * self-report difficulties with physical function * self-report low levels of moderate to vigorous physical activity * self-report high levels of sitting time Exclusion Criteria: * medical condition that interferes with ability to safely stand or stay balanced * other cancer diagnoses that occurred after their breast cancer diagnosis * Stage IV breast cancer with brain metastases or less than 12 months life-expectancy * unable to commit to a 3-month study
References
Publications (0)
Data not yet available
No reference posted for this study.